Dr Shahla Vilcassim

Learn more about Monash Health’s Haematology team.

Dr Shahla Vilcassim

Dr Shahla Vilcassim is a clinical and laboratory haematologist at Monash Health. She is a member of the Monash Haemoglobinopathy Service, the state referral centre for Victoria and the Cancer Care at Home medical lead at Monash Health. Dr Vilcassim completed her PhD on “Iron Dysregulation in the Myelodysplastic Syndromes” at the Hudson Institute of Medical Research and is an Adjunct Research Associate at Monash University.

Recent publications

Shahla Vilcassim, Nuttanan Pholngam, Rattanawan Thubthed, Tiwaporn Nualkaew, Saovaros Svasti, Pornthip Chaichompoo, Kai Kysenius, Peter J. Crouch, Sibylle Dames, Mona Eiserman, Alberto Martinez, Ute Schaeper, Jim Vadolas & George Grigoriadis. Therapeutic Silencing of Tmprss6 Reduces Iron-Induced Inflammation and Prolongs Survival in MDS Mice. American Journal of Hematology. May 2026

Vadolas J, Nualkaew T, Hsiao PJ Voon, Vilcassim S, Grigoriadis G. Interplay between -thalassaemia and -globinopathies: Translating genotype-phenotype relationships into therapies. Hemasphere. 2024 May 15;8(5):e78. doi: 10.1002/hem3.78.

Vadolas J, Ng G, Kysenius K, Crouch PJ, Dames S, Eisermann M, Nualkaew T, Vilcassim S, Schaeper U and Grigoriadis G.
SLN124, a GalNac‐siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron‐overload in a mouse model of β‐thalassaemia. Br J Haematol. 2021 Jul; 194(1): 200–210. doi:10.1111/bjh.17428

Lucy. Fox, ZoeK. McQuilten, Frank Firkin, Vanessa Fox, Xavier Badoux, Ashish Bajel, Pasquale Barbaro, Merrole F. Cole-Sinclair, Cecily Forsyth, John Gibson, Devendra, K. Hiwase, Anna Johnston, Anthony Mills, Fernando Roncolato Robyn Sutherland, Jeff Szer, Stephen B. Ting, Shahla Vilcassim, Lauren Young , Neil A. Waters, Erica M. Wood. The Australian Aplastic Anaemia and other Bone Marrow Failure Syndromes Registry. Best Practise & Research Clinical Haematology. December 2023